Skip to main content
. 2020 Jul 14;9(7):e16319. doi: 10.2196/16319

Table 4.

The reach, effectiveness, adoption, implementation, and maintenance evaluation measures of Hydroxyurea Toolbox implementation.

Domains Measures Data sources
Adoption—clinic
  • Proportion and representativeness of clinics that agree to support the HUa Toolbox

  • Institutional data to describe clinics (eg, size, case mix, years in service, regional sociodemographics of SCDb patients)

  • Clinic data collection form

  • Qualitative interviews

Adoption—provider
  • Characteristics of providers at each site (eg, specialty, years in practice, sociodemographics, level of expertise)

  • Proportion and representativeness of eligible providers approached in the study (numerator) among all providers (denominator)

  • Proportion and representativeness of enrolled providers in the study (numerator) among all eligible providers (denominator) at each site

  • Provider survey

  • Clinic data collection form

Effectiveness
  • Number and proportion of providers demonstrating improved knowledge and self-efficacy in hydroxyurea administration

  • Percentage of patients who were prescribed hydroxyurea per provider

  • Provider survey

  • Medical chart abstraction

  • Qualitative interviews

Implementation
  • Consistency with which sites are able to implement the use of the Toolbox app as planned

  • Engagement with the app: Percentage, number, and representativeness of providers that appropriately used HU Toolbox app (low or high use; in the entire practice)

  • Percentage of providers who reported satisfaction with HU Toolbox app (MARSc scale)

  • Percentage of patients whose provider used the Toolbox at each site

  • App usage statistics

  • App usage statistics

  • Provider survey

  • Qualitative interviews

Maintenance/sustainability
  • Extent to which program leaders express a desire or intent to offer or encourage the use of the Toolbox app by their clinical providers at the conclusion of the research

  • Percentage of providers who continue to use the provider app beyond the study period, and representativeness

  • Percentage of providers who continue to prescribe hydroxyurea to their patients

  • App usage statistics

  • Clinic data collection form

  • Qualitative interviews

aHU: Hydroxyurea.

bMARS: mobile app rating scale.

bSCD: sickle cell disease.